Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > CETUXIMAB

CETUXIMAB

pharmaceutical raw materials
CETUXIMAB structure

CETUXIMAB 

structure
  • CAS No:

    205923-56-4

  • Formula:

    C6484H10042N1732O2023S36

  • Chemical Name:

    CETUXIMAB

  • Synonyms:

    CETUXIMAB;Erbitux;Hsdb 7454;Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer;Unii-pqx0D8J21j;EGFR antibody;IMC 225;CetuxiMab(C225)

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

CETUXIMAB Basic Attributes

2756.23406

226.110611

Characteristics

3.51

1.0±0.1 g/cm3

371.9±44.0 °C at 760 mmHg

178.7±28.4 °C

1.554

CETUXIMAB Use and Manufacturing

Treatment of EGF receptor-expressing cancers (monoclonal antibod.

Drug Function and Efficacy

This product can specifically bind to the EGF receptor expressed on the surface of normal cells and various cancer cells, and competitively block the binding of EGF and other ligands, such as transforming growth factor-α (TGF-α). By inhibiting the tyrosine kinase (TK) that binds to the EGF receptor, it blocks the intracellular signal transduction pathway, thereby inhibiting the proliferation of cancer cells, inducing apoptosis of cancer cells, and reducing the production of matrix metalloproteinases and vascular endothelial growth factor.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Recommended Suppliers of CETUXIMAB

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.